3 August 2018 in BioMedical Engineering OnLine
The area of application of electronic stethoscopes in medical diagnostics covers the scope of usability of the acoustic stethoscopes, from which they have evolved and which they could potentially replace. However, the principle of operation of these two groups of diagnostic devices is substantially different. Thus, an important question arises, regarding the differences in parameters of the transmitted sound and their potential diagnostic consequences in clinical practice. In order to answer this question, heart auscultation signals are recorded using various stethoscopes and divided into short fragments based on the analysis of the synchronized recordings of electrocardiogram signals. Next, a dedicated algorithm is used to extract representative datasets for each case, which are then analyzed for their acoustic parameters. Four different electronic stethoscopes were investigated, together with an acoustic stethoscope as a reference point. The determined acoustic characteristics of the considered stethoscopes differ significantly between each other. The differences in sound transmitted by various stethoscope models may translate into significant differences in quality of the obtained diagnosis. It is also pointed out, that the terminology and application guidelines regarding the electronic stethoscopes are misleading and should be changed.
30 November 2020 in Rheumatology
KRKatarzyna Romanowska-Próchnicka
Katarzyna Romanowska-Próchnicka
Objectives: To evaluate the prevalence and risk factors of new-onset glucose metabolism impairment using an oral glucose tolerance test (OGTT) in patients with normal fasting glycaemia on long-term glucocorticoid (GC) treatment. Methods: An OGTT was performed in 150 patients without a previous history of pre-diabetes or diabetes who were diagnosed with inflammatory rheumatic diseases and treated with GCs >3 months. All participants underwent clinical and biochemical evaluation for risk factors of diabetes: age, sex, current and cumulative dose of steroids, treatment duration, waist circumference, BMI, Homeostatic Model Assessment for Insulin Resistance, fasting insulin concentration, family history of diabetes, CRP, 28-joint DAS with CRP, type of connective tissue disease and trunk fat percentage measured by DXA. Logistic regression analysis was conducted to evaluate the association between the presence of impaired glucose tolerance (IGT) in the OGTT and analysed risk factors. Results: A total of 102 patients (68%) had fully normal glucose tolerance. Diabetes, isolated impaired fasting glucose, isolated IGT and combined impaired fasting glucose + IGT was diagnosed in 3.3, 4.67, 19.33 and 4.67% of patients, respectively; 20% of participants had IGT or diabetes despite normal fasting glucose concentration. The median cumulative dose and current dose (5 mg) of GCs and treatment duration were similar compared with the normal glucose tolerance group. In a multivariate logistic regression model, only older age (particularly ≥50 years of age) and trunk fat percentage remained significant factors predicting IGT or diabetes in the OGTT. Conclusion: New-onset GC-induced glucose intolerance, even in patients on long-term low-dose treatment, is prevalent despite normal fasting glucose concentration and patients should be screened with an OGTT despite the absence of classic risk factors of diabetes.
1 February 2021 in European Journal of Endocrinology
Adrenocortical carcinoma (ACC) is an orphan disease lacking effective systemic treatment options. The low incidence of the disease and high cost of clinical trials are major obstacles in the search for improved treatment strategies. As a novel approach, registry-based clinical trials have been introduced in clinical research, so allowing for significant cost reduction, but without compromising scientific benefit. Herein, we describe how the European Network for the Study of Adrenal Tumours (ENSAT) could transform its current registry into one fit for a clinical trial infrastructure. The rationale to perform randomized registry-based trials in ACC is outlined including an analysis of relevant limitations and challenges. We summarize a survey on this concept among ENSAT members who expressed a strong interest in the concept and rated its scientific potential as high. Legal aspects, including ethical approval of registry-based randomization were identified as potential obstacles. Finally, we describe three potential randomized registry-based clinical trials in an adjuvant setting and for advanced disease with a high potential to be executed within the framework of an advanced ENSAT registry. Thus we, therefore, provide the basis for future registry-based trials for ACC patients. This could ultimately provide proof-of-principle of how to perform more effective randomized trials for an orphan disease.
1 March 2017 in The Journal of the Acoustical Society of America
The present study introduces a detailed methodology which can be applied for objective evaluation and comparison of the acoustic parameters of medical stethoscopes using auscultation sounds as test signals. The described approach allows taking into account the acoustic coupling between the body of an auscultated patient and the chest piece of a stethoscope. Information obtained from additional, synchronized electrocardiography measurements is used to extract short, specific fragments of recordings, defined as acoustic events. Analysis of the spectral characteristics of many acoustic events allows us to compare the acoustic properties of various stethoscopes and to estimate the measurement uncertainty. The exemplary results of the comparative evaluation of acoustic properties of bell and diaphragm-type chest pieces of a single stethoscope are presented. The results show that the frequency characteristics of the signals obtained using both examined chest pieces under the conditions of the performed examinations are very similar.
1 December 2019 in Applied Acoustics
10 August 2017 in Endokrynologia Polska
KRKatarzyna Roszkowska-Purska
Katarzyna Roszkowska-Purska
+1
Introduction: There is an increasing number of adrenal being tumours discovered incidentally during imaging examinations performed for many different indications. Radiological findings suggesting adrenal pathology may be caused by true adrenal tumours or by other retroperitoneal masses. Generally, the larger the tumour, the higher the possibility of adrenal cancer. Material and methods: Analysis of our data — 139 operations performed over 11 years (2004–2014) in patients with tumours in the adrenal area larger than 5 cm. Results: The most common finding was adrenal cancer (25.2%), benign adenoma (24.5%), pheochromocytoma (12.9%), and metastatic cancer (10.1%). In total, there were 19 various histopathological diagnoses in this group. Conclusion: Although adrenal cancer is the most likely diagnosis in large adrenal tumours, a broad spectrum of various adrenal and retroperitoneal tumours with size more than 5 cm can be found in such patients. Introduction: There is an increasing number of adrenal being tumours discovered incidentally during imaging examinations performed for many different indications. Radiological findings suggesting adrenal pathology may be caused by true adrenal tumours or by other retroperitoneal masses. Generally, the larger the tumour, the higher the possibility of adrenal cancer. Material and methods: Analysis of our data — 139 operations performed over 11 years (2004–2014) in patients with tumours in the adrenal area larger than 5 cm. Results: The most common finding was adrenal cancer (25.2%), benign adenoma (24.5%), pheochromocytoma (12.9%), and metastatic cancer (10.1%). In total, there were 19 various histopathological diagnoses in this group. Conclusion: Although adrenal cancer is the most likely diagnosis in large adrenal tumours, a broad spectrum of various adrenal and retroperitoneal tumours with size more than 5 cm can be found in such patients.